Among the 1,405 people who participated in the trial between October 2020 and August 2021, about 24% of those who took the drug said they experienced pain freedom two hours after treatment compared to 15% of people in the placebo group.
FDA approves nasal spray zavegepant to treat migraine symptoms (usatoday.com)
21% reported it distorted their taste and an unspecified number experienced face swelling and hives.
I have suffered – badly – from visual auras and migraines. I believe I have at long last found the root cause of the frequent (up to daily in recent months) visual auras and visual disturbances. I will likely share this information in a week or two as I am still in the waiting phase to make sure the root cause was found. Assuming I share this soon, you will see instantly why I would never take this Pfizer drug.